Discover and read the best of Twitter Threads about #s217622
Most recents (1)
Ensitrelvir or S-217622, a potent inhibitor of SARCov2 main protease from Japan shows activity against COVID19 Variants of concern in animals studies and is poised to enter clinical trials.
#COVID19 #Ensiltrevir #Japan #ProteaseInhibitor #S217622
science.org/doi/10.1126/sc…
#COVID19 #Ensiltrevir #Japan #ProteaseInhibitor #S217622
science.org/doi/10.1126/sc…
Ensiltrevir blocks SARSCov2 Main protease after viral entry. #Ensiltrevir science.org/doi/10.1126/sc… 
Prophylactic treatment of S-217622 controls viral burden and disease in hamsters inoculated with SARS-CoV-2
science.org/doi/10.1126/sc…
science.org/doi/10.1126/sc…
